Surgical Outcomes of Lung Cancer Patients with Combined Pulmonary Fibrosis and Emphysema and Those with Idiopathic Pulmonary Fibrosis without Emphysema.
Seijiro Sato, T. Koike, T. Hashimoto, H. Ishikawa, A. Okada, Takehiro Watanabe, M. Tsuchida
{"title":"Surgical Outcomes of Lung Cancer Patients with Combined Pulmonary Fibrosis and Emphysema and Those with Idiopathic Pulmonary Fibrosis without Emphysema.","authors":"Seijiro Sato, T. Koike, T. Hashimoto, H. Ishikawa, A. Okada, Takehiro Watanabe, M. Tsuchida","doi":"10.5761/atcs.oa.15-00315","DOIUrl":null,"url":null,"abstract":"OBJECTIVES\nCombined pulmonary fibrosis and emphysema (CPFE) is a unique disorder. The aim of this study was to compare the surgical outcomes of lung cancer patients with CPFE and those with idiopathic pulmonary fibrosis (IPF) without emphysema.\n\n\nMETHODS\nA total of 1548 patients who underwent surgery for primary lung cancer between January 2001 and December 2012 were retrospectively reviewed.\n\n\nRESULTS\nOf the 1548 patients, 55 (3.6%) had CPFE on computed tomography (CT), and 45 (2.9%) had IPF without emphysema. The overall and disease-free 5-year survival rates for patients with CPFE were not significantly worse than those for patients with IPF without emphysema (24.9% vs. 36.8%, p = 0.814; 39.8% vs. 39.3%, p = 0.653, respectively). Overall, 21 (38.1%) patients with CPFE and nine patients (20.0%) with IPF without emphysema developed postoperative cardiopulmonary complications. Patients with CPFE had significantly more postoperative cardiopulmonary complications involving pulmonary air leakage for >6 days, hypoxemia, and arrhythmia than patients with IPF without emphysema (p = 0.048).\n\n\nCONCLUSIONS\nThere was no significant difference in survival after surgical treatment between CPFE patients and IPF patients without emphysema, but CPFE patients had significantly higher morbidity than IPF patients without emphysema.","PeriodicalId":93877,"journal":{"name":"Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2016-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"15","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5761/atcs.oa.15-00315","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 15
Abstract
OBJECTIVES
Combined pulmonary fibrosis and emphysema (CPFE) is a unique disorder. The aim of this study was to compare the surgical outcomes of lung cancer patients with CPFE and those with idiopathic pulmonary fibrosis (IPF) without emphysema.
METHODS
A total of 1548 patients who underwent surgery for primary lung cancer between January 2001 and December 2012 were retrospectively reviewed.
RESULTS
Of the 1548 patients, 55 (3.6%) had CPFE on computed tomography (CT), and 45 (2.9%) had IPF without emphysema. The overall and disease-free 5-year survival rates for patients with CPFE were not significantly worse than those for patients with IPF without emphysema (24.9% vs. 36.8%, p = 0.814; 39.8% vs. 39.3%, p = 0.653, respectively). Overall, 21 (38.1%) patients with CPFE and nine patients (20.0%) with IPF without emphysema developed postoperative cardiopulmonary complications. Patients with CPFE had significantly more postoperative cardiopulmonary complications involving pulmonary air leakage for >6 days, hypoxemia, and arrhythmia than patients with IPF without emphysema (p = 0.048).
CONCLUSIONS
There was no significant difference in survival after surgical treatment between CPFE patients and IPF patients without emphysema, but CPFE patients had significantly higher morbidity than IPF patients without emphysema.
目的:合并肺纤维化和肺气肿(CPFE)是一种独特的疾病。本研究的目的是比较伴有CPFE的肺癌患者和伴有特发性肺纤维化(IPF)而无肺气肿的患者的手术结果。方法回顾性分析2001年1月至2012年12月期间接受原发性肺癌手术治疗的1548例患者。结果1548例患者中,55例(3.6%)CT表现为CPFE, 45例(2.9%)无肺气肿IPF。CPFE患者的总5年生存率和无病5年生存率并不明显差于无肺气肿的IPF患者(24.9% vs 36.8%, p = 0.814;39.8% vs. 39.3%, p = 0.653)。总体而言,21例(38.1%)CPFE患者和9例(20.0%)无肺气肿的IPF患者出现术后心肺并发症。与无肺气肿的IPF患者相比,CPFE患者的术后心肺并发症(肺漏气>6天、低氧血症、心律失常)明显增加(p = 0.048)。结论CPFE患者与无肺气肿的IPF患者手术后生存率无显著差异,但CPFE患者的发病率明显高于无肺气肿的IPF患者。